PlumX Metrics
Embed PlumX Metrics

Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience

Radiotherapy and Oncology, ISSN: 0167-8140, Vol: 99, Issue: 2, Page: 120-123
2011
  • 70
    Citations
  • 0
    Usage
  • 54
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

Hilar cholangiocarcinoma (Klatskin tumor–KT) accounts for about 0.5–1.5% of all gastrointestinal cancers and for 40–60% of all biliary malignancies. Tumor resection is attainable in about 30–50% of patients. When resection is not possible other treatment options have little or no impact on survival. We present the results of hypofractionated Stereotactic Body Radiotherapy (SBRT) on a small series of non resectable locally advanced KT patients.

Bibliographic Details

Polistina, Francesco Antonio; Guglielmi, Rosabianca; Baiocchi, Cristina; Francescon, Paolo; Scalchi, Paolo; Febbraro, Antonio; Costantin, Giorgio; Ambrosino, Giovanni

Elsevier BV

Medicine

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know